https://www.marketscreener.com/quote/stock/IMMUNE-DESIGN-CORP-16953839/news/Immune-Design-Announces-Launch-of-Web-Portal-for-SYNOVATE-Phase-3-Study-of-CMB305-Immunotherapy-in-S-26648550/?utm_source=telegram&utm_medium=social&utm_campaign=share